Abstract:Colon cancer is a digestive tract tumor with one of the highest frequencies worldwide, and with a high fatality rate. The present study aimed to investigate the expression and regulation of inflammatory factors in tumor tissues, monocytes and blood samples in patients with colon cancer (n=46) following treatment with neoadjuvant chemotherapy combined with tetrandrine. All patients underwent tumor resection after neoadjuvant chemotherapy. In the experimental group, 20 cases took tetrandrine during chemotherapy, while in the control group, 26 cases underwent chemotherapy without tetrandrine. Reverse transcription-quantitative PCR and western blotting were performed to detect the mRNA and protein expression levels of TNF-α. ELISA was used to detect the cytokine/chemokine expression levels [IL-15, IL-1β and IL-6, as well as chemokine ligand (CCL)2, CCL5, CCL20, chemokine (C-X-C motif) ligand CXCL1, CXCL2, CXCL3, CXCL5 and CXCL10 in the culture supernatant of colon cancer tissue]. Human blood mononuclear cells were cultured, and cytokine release was determined by ELISA. Cell proliferation ability was assessed using the MTT assay. Compared with the control group, the mRNA and protein expression levels of tumor necrosis factor-α (TNF-α) were downregulated in tumor tissues and serum and the serum levels of IL-15, IL-1β and IL-6 were relatively low in the experimental group. The expression levels of CCL5, CXCL2 and CXCL10 in the supernatant of cancer tissue culture were relatively low, compared with the conditioned medium prepared from tumor tissues of patients not receiving tetrandrine. When the cultured blood mononuclear cells were stimulated by the tissue culture supernatant from the experimental group, less IL-15, IL-1β and IL-6 were released, compared with the medium of tumor tissues of patients not taking tetrandrine. Following stimulation with the tissue culture supernatant from the experimental group, the proliferation ability of HCT116 colon cancer cells significantly declined. During chemotherapy of patients with colon cancer, tetrandrine may inhibit the expression of TNF-α in cancer tissues and blood, reduce the release of inflammatory factors and chemokines and decrease cancer cell proliferation. These findings provide a theoretical basis for the treatment of colon cancer in the clinic.

Antineoplastic effect of tetrandrine on primary cancer cells isolated from ascites

Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids.

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer

Antagonistic effect of tetrandrine on multidrug resistance of breast cancer cells and the antioxidant mechanism

Tetrandrine Enhances the Anticancer Effects of Arsenic Trioxide in Vitro

Tetrandrine, A Chinese Plant-Derived Alkaloid, Is A Potential Candidate For Cancer Chemotherapy

Effects of Tetrandrine on Apoptosis and Radiosensitivity of Nasopharyngeal Carcinoma Cell Line CNE

The Effects of Tetrandrine on Proliferation and Apoptosis of Hunman Ovarian Cancer Cell Line A2780

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Tetrandrine Suppresses Cervical Cancer Growth by Inducing Apoptosis in Vitro and in Vivo

Study on the efficacy of Tetrandrine in inducing the apoptosis of neuroblastoma cells

Enhancement of Radiosensitivity and the Potential Mechanism on Human Esophageal Carcinoma Cells by Tetrandrine

Tetrandrine Inhibits Cancer Stem Cell Characteristics and Epithelial to Mesenchymal Transition in Triple-Negative Breast Cancer via SOD1/ROS Signaling Pathway.

Tetrandrine Induces Apoptosis in Gallbladder Carcinoma in Vitro.

[Inhibitory Effect of Tetrandrine on Angiogenesis].

Combination Of Tetrandrine With Cisplatin Enhances Cytotoxicity Through Growth Suppression And Apoptosis In Ovarian Cancer In Vitro And In Vivo

Tetrandrine Suppresses Adhesion, Migration and Invasion of Human Colon Cancer SW620 Cells Via Inhibition of Nuclear Factor-Κb, Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Signaling Pathways

Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells.

Effect of tetrandrine on murine hemangioendothelioma cell and its molecular mechanisms